Perampanel Study 207: long-term open-label evaluation in patients with epilepsy

Abstract

Long-term - up to 4 years - adjunctive perampanel had a favourable tolerability profile in patients with refractory partial-onset seizures. Improvements in seizure control were maintained with long-term treatment.